Skip to contentI
InspireMD, Inc.
I
NSPRInspireMD, Inc. Q3 2015 · 10-Q
Revenue$632.00K$632.00K+131.5% vs Q3 2014 Net Income-$3.64M-$3.64MN/M vs Q3 2014 EPS Diluted-$11.93-$11.93N/M vs Q3 2014 The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
InspireMD, Inc. · CIK 1433607 · Engraved from SEC EDGAR
Operating Cash Flowderived-$2,334,000N/M Free Cash Flowderived-$2,345,000N/M Margins · derivedGross margin14.1%+41.9 pt vs Q3 2014
Operating margin-539.7%+1834.3 pt vs Q3 2014
Net margin-576.1%+1905.6 pt vs Q3 2014
ended Sep 30, 2015 · filed Nov 9, 2015 · 40 d after period end